#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dilated cardiomyopathy Pustular psoriasis Glomerulonephritis membranous Post transplant lymphoproliferative disorder Henoch-Schonlein purpura Palmoplantar pustulosis Heavy menstrual bleeding Head and neck cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Chronic lymphocytic leukaemia refractory Acute graft versus host disease in liver Idiopathic pulmonary fibrosis Cognitive disorder Bronchopulmonary dysplasia Hypereosinophilic syndrome More trials…

    Learn about Rare Diseases

    Ocular melanoma – Basic Information Hyperoxaluria – Life with Disease Rett syndrome – Basic Information Sjogren’s syndrome – Diagnostics Pleomorphic leiomyosarcoma – Diagnostics Hereditary neuropathic amyloidosis – Diagnostics Combined immunodeficiency – Diagnostics Mucopolysaccharidosis I Krabbe’s disease – Treatment Small intestine leiomyosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    DAPIGLUTIDE Rigosertib Sodium Tamsulosin Hydrochloride Masitinib Ibuprofen Sodium Dihydrate Vidutolimod Magnesium Chloride Methadone Hydrochloride Sisunatovir Obinutuzumab Revumenib Bictegravir Emraclidine SC0062 177LU-PSMA-I&T Guselkumab Pevonedistat Resmetirom Relebactam Iopamidol More therapies…

    Learn about Your Condition

    Ependymoma malignant Arterial disorder Transplant rejection Still's disease Epiphysiolysis Tumour of ampulla of Vater Glomerulonephritis chronic Vulval cancer Carpal tunnel syndrome Chondropathy Fontan procedure Mast cell activation syndrome Electrocorticogram Hyperoxaluria Thyroidectomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes

    Not recruiting

    2 1
    Investigated Drugs:
    • Maridebart Cafraglutide
    Austria Greece Hungary Italy Poland Romania +2

  • Study on the Safety and Effectiveness of ALKS 2680 for Patients with Narcolepsy Type 1

    Not recruiting

    2 1
    Investigated Diseases:
    • Narcolepsy
    Investigated Drugs:
    • Alks 2680
    Belgium Czechia France Italy The Netherlands Spain

  • Study on the Effectiveness and Safety of Remibrutinib for Teens with Chronic Spontaneous Urticaria Not Controlled by H1-Antihistamines

    3 1 1
    Investigated Diseases:
    • Chronic spontaneous urticaria
    Investigated Drugs:
    • Corticosteroids For Systemic Use, Plain
    • Remibrutinib
    Germany Italy The Netherlands Poland Spain
Previous Page
1 … 1,652 1,653 1,654

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!